SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-19-023744
Filing Date
2019-11-15
Accepted
2019-11-15 16:39:39
Documents
4

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 posam232332a1_delmar.htm POS AM 264816
2 CONSENT OF ERNST & YOUNG, LLP posam232332a1ex23-1_delmar.htm EX-23.1 3189
3 GRAPHIC image_001.jpg GRAPHIC 26883
4 GRAPHIC image_002.jpg GRAPHIC 35226
  Complete submission text file 0001213900-19-023744.txt   354893
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-232332 | Film No.: 191225009
SIC: 2834 Pharmaceutical Preparations